BioSpace News Archive

Lantern Pharma will present virtually on Thursday, March 7th at 2 pm Eastern.

FSD Pharma Inc. today announced its participation in Americas Committee for Treatment and Research in Multiple Sclerosis 2024 Forum held during Feb. 29 - Mar 2, 2024, in West Palm Beach, Florida.

Telomir Pharmaceuticals, Inc. announced that Michael F. Roizen, MD, a leader in age-related medicine and an existing advisor to the Company, will be increasing his role in the coming months as a Special Advisor on Age Reversal.

Aptevo Therapeutics Inc. today reported financial results for the year ended December 31, 2023 and provided a business update.

Regen BioPharma, Inc. will be presenting at the Emerging Growth Conference on March 7, 2024.

Zoetis Inc. (NYSE:ZTS) will participate in the Barclays Global Healthcare Conference on Thursday, March 14, 2024.

MBrace™ Therapeutics, Inc. today announced the appointment of Steve Alley, Ph.D., as chief scientific officer.

Sunbird Bio today announced new data demonstrating that their APEX (Amplified Plasmonic EXosomes) amyloid beta (Aβ) test, the company’s investigational blood-based diagnostic in Alzheimer’s disease, effectively discriminated between patients who were positive versus negative for Aβ on positron emission tomography (PET) scans.

Accelus announced today its participation in the prestigious LSI USA ’24 conference at the Monarch Beach Resort, Waldorf Astoria, in Dana Point, Calif.

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, and the American Academy of HIV Medicine jointly announced the launch of The Dr. Dawn K. Smith HIV Prevention Clinical Fellowship.